Adam, I just saw your post re Teva. I have no idea what their strategic review means for MSB is anything. I assume it does not cover MSB at all, but who knows in this day and age. I'm really growing tired of companies releasing statements that create more questions and doubts among investors. They really do treat shareholders with contempt. It happens here and overseas on a daily basis. In fact it infuriates me. Just like the downtrodden MSB share price. But I am a true believer and will hold tight even though I'm way, way under water.
MSB 0_o, page-36
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |